From the Journals

In and out surgeries become the norm during pandemic


 

Case studies in nephrectomy

While several case studies have looked at the feasibility and safety of performing partial and radical nephrectomy with same-day discharge in select cases, “this topic has not been addressed on a national level,” Mr. Garden said.

Few patients who have partial or radical nephrectomies have same-day discharges. The researchers found that fewer than 1% of patients who have either procedure in the sample studied were discharged the same day.

Researchers used the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database, a nationally representative deidentified database that prospectively tracks patient characteristics and 30-day perioperative outcomes for major inpatient and outpatient surgical procedures at more than 700 hospitals.

They extracted all minimally invasive partial and radical nephrectomies from 2012 to 2019 and refined the cohort to 28,140 patients who were theoretically eligible for same-day discharge: Of those, 237 (0.8%) had SSD, and 27,903 (99.2%) had a standard-length discharge (SLD).

The team found that there were no differences in 30-day complications or readmissions between same-day discharge (Clavien-Dindo [CD] I/II, 4.22%; CD III, 0%; CD IV, 1.27%; readmission, 4.64%); and SLD (CD I/II, 4.11%; CD III, 0.95%; CD IV, 0.79%; readmission, 3.90%; all P > .05).

Controlling for demographic and clinical variables, SDD was not associated with greater risk of 30-day complications or readmissions (CD I/II: odds ratio, 1.08; 95% confidence interval, 0.57-2.048; P = .813; CD IV: OR 1.699; 95% CI, 0.537-5.375; P = .367; readmission: OR, 1.254; 95% CI, 0.681-2.31; P = .467).

Mr. Garden and coauthors report no relevant financial relationships.

Dr. Lane reports no relevant financial relationships.

Pages

Recommended Reading

Many patients, doctors unaware of advancements in cancer care
MDedge Internal Medicine
MRI screening cost effective for women with dense breasts
MDedge Internal Medicine
Biomarker testing in metastatic breast cancer management: ‘Essential’
MDedge Internal Medicine
New approval in early breast cancer: First advance in 20 years
MDedge Internal Medicine
No advantages to using ADM in implant-based breast reconstruction
MDedge Internal Medicine
Neuroimaging may predict cognitive decline after chemotherapy for breast cancer
MDedge Internal Medicine
Does eating nuts lead to better breast cancer outcomes?
MDedge Internal Medicine
Convenience, not outcomes may drive robot-assisted surgeries
MDedge Internal Medicine
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes
MDedge Internal Medicine
FDA issues stronger safety requirements for breast implants
MDedge Internal Medicine